Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
2251043
Reference Type
Journal Article
Title
Compatibility of selected critical care drugs during simulated Y-site administration
Author(s)
Yamashita, SK; Walker, SE; Choudhury, T; Iazzetta, J
Year
1996
Is Peer Reviewed?
Yes
Journal
American Journal of Health-System Pharmacy
ISSN:
1079-2082
EISSN:
1535-2900
Report Number
IPA/96/1102198
Volume
J
Issue
REF 5
Page Numbers
1048-1051
Language
eng
Abstract
IPA COPYRIGHT: ASHP A study evaluating the compatibility of 12 drugs commonly used in critical care when combined in 35 different combinations diluted with 5% dextrose, combined under simulated Y-site conditions, and observed for 24 h at room temperature is reported. Five combinations were incompatible in a concentration-dependent fashion. Human insulin (Humulin R) and labetalol hydrochloride were inconsistently compatible at 1 unit/ml of insulin and up to 5 mg/ml of labetalol. Insulin was compatible with <3 mg/ml of dopamine hydrochloride. Norepinephrine bitartrate and insulin developed a precipitate when norepinephrine exceeded 0.05 mg/ml; lower concentrations appeared to be compatible with higher insulin concentrations. Heparin sodium was incompatible with labetalol at concentrations of 1-2.5 mg/ml and heparin concentrations of as low as 4 units/ml. Heparin was also incompatible with dobutamine hydrochloride at dobutamine concentrations of 1-2 mg/ml, and with 1.6-3.25 mg/ml of nitroglycerin.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity